Chemed Corp

Chemed Corporation merges health‑care and home‑maintenance services, boasting a $5.8B market cap, NYSE listing, and a 23.6 P/E—an attractive investment for those eyeing diverse, growing sectors.

Chemed Corp’s Q1 2026 results show steady revenue growth and a GF Score of 77, suggesting possible undervaluation amid a 3.1% price dip.

Chemed Corporation secures a $450 million revolving credit line, boosting liquidity, flexibility for acquisitions and growth in healthcare and restoration services.

Chemedickefter partneravtal med SynAct Pharma bolaget" 192" 192368789" 192368" 192368789" 192368" 192" 192368" 192" 192" " 19236837211119,“SynAct Pharma SynAct SynAct Pharma rusar på licensav SynAct Pharma Saniona rusar har inlett onsdagens han…

Chemed Corporation, a diversified health care and home services company, demonstrates strong operational capabilities and market positioning, with a stable stock price and growth potential.